HSP90AB1 and neoplasm: Eustace and colleagues tested DMAG-N-oxide, a cell membrane-impermeable geldanamycin/17-AAG-derived inhibitor that targets the ATPase activity of Hsp90, and showed that it inhibits tumour cell invasion [20].